BRIEF-Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology To Accelerated Cognitive Decline In Parkinson's Patients
BRIEF-Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology To Accelerated Cognitive Decline In Parkinson's PatientsAnnovis Bio Inc ANVS.N:
ANNOVIS REPORTS NEW BIOMARKER DATA LINKING AMYLOID CO-PATHOLOGY TO ACCELERATED COGNITIVE DECLINE IN PARKINSON'S PATIENTS
ANNOVIS BIO INC - BUNTANETAP IMPROVES COGNITION IN PARKINSON'S WITH AMYLOID CO-PATHOLOGY
Source text: ID:nGNX7Sr0tt
Further company coverage: ANVS.N
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。